Gilead Sciences News - August 2026

Gilead's second quarter revenue grew 10% to $7.8B, beating estimates, but reported a larger-than-expected loss on acquisition charges.
GILD

Gilead's second quarter revenue grew 10% to $7.8B, beating estimates, but reported a larger-than-expected loss on acquisition charges.

Gilead Sciences reported second quarter 2026 revenue of $7.8 billion, a 10% increase year-over-year, driven by strong performance in its core business....
GILD

Gilead Sciences Inc Q2 2026 Earnings Preview: What Analysts Expect on August 04, 2026

Gilead Sciences is expected to report Q2 2026 revenue of $7.40 billion and a consensus loss of $7.07 per share, with the stock currently trading at $130.26...